Search results
BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Simply Wall St. via Yahoo Finance· 3 hours agoInvestors in BioNTech SE (NASDAQ:BNTX) had a good week, as its shares rose 2.3% to close at US$90.88...
BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 23 hours agoBioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the...
BioNTech Target of Unusually Large Options Trading (NASDAQ:BNTX)
ETF DAILY NEWS· 12 hours agoBioNTech SE (NASDAQ:BNTX – Get Free Report) was the recipient of some unusual options trading on Monday. BMO Capital Markets cut their price objective on BioNTech ...
BioNTech reports net loss of €315.1m in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 1 day agoBioNTech has experienced a significant shift in its financial standing, reporting a net loss of €315.1m ($339.3m) in the first quarter (Q1) of 2024. This...
BioNTech shares dip 2% on earnings and revenue miss By Investing.com
Investing.com· 2 days agoShares of BioNTech SE (NASDAQ:BNTX) fell 2.2% following the announcement of the first quarter...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 2 days agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
European regulator pulls authorization for AstraZeneca's COVID shot
ABC News· 2 hours agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 1 week agoOn BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 2 days agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
Cracking The Code: Understanding Analyst Reviews For BioNTech - BioNTech (NASDAQ:BNTX)
Benzinga· 20 hours agoLoading... Loading... Throughout the last three months, 12 analysts have evaluated BioNTech BNTX , offering a diverse set of opinions from bullish to bearish. The table below ...
